Hector M González1, Wassim Tarraf, Keith Whitfield, Joseph J Gallo. 1. Wayne State University, Institute of Gerontology, Department of Family Medicine and Public Health Sciences, 87 East Ferry Street, 226 Knapp Building, Detroit, MI 48202, USA. hmgonzalez@med.wayne.edu
Abstract
OBJECTIVE: To examine and describe vascular depression epidemiology in the United States. METHODS: Cross-sectional data from a national probability sample of household resident adults (18-years and older; N = 16,423) living in the 48 coterminous United States were analyzed to calculate prevalence estimates of vascular depression, associated disability and treatment rates. In this study, vascular depression was defined as the presence of cardiovascular and cerebrovascular disease (CVD) and CVD major risk factors (e.g., diabetes, hypertension, heart disease, and obesity) among adults 50-years and older who also met 12-month DSM-IV major depression criteria. RESULTS: We estimated that about 3.4% or approximately 2.64 million American adults 50-years and older met our criteria for vascular depression. Among adults who met criteria for lifetime major depression, over one-in-five (22.1%) were considered to have the vascular depression subtype. Secondly, vascular depression was associated with significantly increased functional impairment relative to the non-depressed population and adults meeting criteria for major depression alone. Although depression care use was significantly higher among vascular depression respondents relative to those with major depression alone, practice guideline concordant therapy use was not. CONCLUSIONS: Vascular depression appears to be an important public health problem that affects a large portion of the U.S. adult population with major depression, and that it is associated with excess functional impairment without concomitant better depression care. Copyright Â
OBJECTIVE: To examine and describe vascular depression epidemiology in the United States. METHODS: Cross-sectional data from a national probability sample of household resident adults (18-years and older; N = 16,423) living in the 48 coterminous United States were analyzed to calculate prevalence estimates of vascular depression, associated disability and treatment rates. In this study, vascular depression was defined as the presence of cardiovascular and cerebrovascular disease (CVD) and CVD major risk factors (e.g., diabetes, hypertension, heart disease, and obesity) among adults 50-years and older who also met 12-month DSM-IV major depression criteria. RESULTS: We estimated that about 3.4% or approximately 2.64 million American adults 50-years and older met our criteria for vascular depression. Among adults who met criteria for lifetime major depression, over one-in-five (22.1%) were considered to have the vascular depression subtype. Secondly, vascular depression was associated with significantly increased functional impairment relative to the non-depressed population and adults meeting criteria for major depression alone. Although depression care use was significantly higher among vascular depression respondents relative to those with major depression alone, practice guideline concordant therapy use was not. CONCLUSIONS:Vascular depression appears to be an important public health problem that affects a large portion of the U.S. adult population with major depression, and that it is associated with excess functional impairment without concomitant better depression care. Copyright Â
Authors: Steven G Heeringa; James Wagner; Myriam Torres; Naihua Duan; Terry Adams; Patricia Berglund Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy Journal: Arch Gen Psychiatry Date: 2010-03
Authors: M L Levy; J L Cummings; L A Fairbanks; D Masterman; B L Miller; A H Craig; J S Paulsen; I Litvan Journal: J Neuropsychiatry Clin Neurosci Date: 1998 Impact factor: 2.198
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati Journal: Lancet Date: 2011-02-03 Impact factor: 79.321
Authors: Hector M González; Thomas Croghan; Brady West; David Williams; Randolph Nesse; Wassim Tarraf; Robert Taylor; Ladson Hinton; Harold Neighbors; James Jackson Journal: Psychiatr Serv Date: 2008-10 Impact factor: 4.157
Authors: Alvaro Camacho; Wassim Tarraf; Daniel E Jimenez; Linda C Gallo; Patricia Gonzalez; Robert C Kaplan; Melissa Lamar; Tasneem Khambaty; Bharat Thyagarajan; Krista M Perreira; Rosalba Hernandez; Jianwen Cai; Martha L Daviglus; Sylvia Wassertheil-Smoller; Hector M González Journal: Am J Geriatr Psychiatry Date: 2017-07-03 Impact factor: 4.105
Authors: Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram Journal: JAMA Psychiatry Date: 2017-07-01 Impact factor: 21.596
Authors: Álvaro Camacho; Patricia González; Sheila F Castañeda; Alan Simmons; Christina Buelna; Hector Lemus; Gregory A Talavera Journal: Community Ment Health J Date: 2014-08-09